Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE).
| Author | |
|---|---|
| Abstract |
:
Evaluate apremilast efficacy across various psoriatic arthritis (PsA) manifestations beginning at week 2 in biological-naïve patients with PsA. |
| Year of Publication |
:
2018
|
| Journal |
:
Annals of the rheumatic diseases
|
| Date Published |
:
2018
|
| ISSN Number |
:
0003-4967
|
| URL |
:
http://ard.bmj.com/cgi/pmidlookup?view=long&pmid=29343507
|
| DOI |
:
10.1136/annrheumdis-2017-211568
|
| Short Title |
:
Ann Rheum Dis
|
| Download citation |
